Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesPerrigo Co. PLC

Perrigo Co. PLC

PortfolioPortfolio WatchlistWatchlist
Company price
15.79 GBX -0.01 ( 0.06%)
Last update at 2026-10-27T16:34:00Z
VOLUME
1077
Market Cap
149553.24M

Momentum Score

…

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
15.45
Low
15.95
High
52 Week Price Range
9.28
Low
26.96
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
15.80
Dividend Yield
10.57%
Revenue TTM
4253.10M
Revenue Per Share
30.71
Gross Profit TTM
1494.50M
Debt / Equity
1.35
ROE
-38.66%
Net Debt
3437.30M
ROCE
-15.09%
Diluted EPS TTM
-0.82

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -1297.90M -80.70M -8.30M -139.10M 258.70M
Net income -1425.40M -171.80M -12.70M -130.90M -130.90M
Selling general administrative - 468.00M 522.30M 465.40M 482.00M
Selling and marketing expenses 526.50M 644.60M 752.30M 697.80M 629.40M
Gross profit 1494.50M 1542.70M 1680.40M 1455.40M 1416.20M
Ebit -1135.40M 107.10M 165.50M 168.60M 185.80M
Ebitda -797.90M 433.00M 525.00M 507.20M 498.00M
Depreciation and amortization 337.50M 325.90M 359.50M 338.60M 312.20M
Operating income 343.30M 112.90M 151.90M 168.60M 185.80M
Other operating expenses 3909.80M 4260.50M 4503.70M 4450.00M 3760.30M
Interest expense 162.50M 187.80M 173.80M - 0.00M
Income tax expense 104.40M 80.00M -3.90M 8.20M 389.60M
Total revenue 4253.10M 4373.40M 4655.60M 4451.60M 4138.70M
Total operating expenses 1151.20M 1429.80M 1528.50M 1453.80M 1037.80M
Cost of revenue 2758.60M 2830.70M 2975.20M 2996.20M 2722.50M
Total other income expense net -1641.20M -193.60M -160.20M -307.70M 72.90M
Discontinued operations - - - -9.70M 62.00M
Net income applicable to common shares - - - -140.60M -68.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 8535.20M 9647.70M 10809.10M 11017.30M 10425.70M
Intangible assets 2351.50M 2428.90M 2986.10M 3288.80M 2151.40M
Other current assets 504.00M 199.00M 201.10M 230.20M 281.30M
Total liab 5599.70M 5328.30M 6041.20M 6175.20M 5274.00M
Total stockholder equity 2935.50M 4319.40M 4767.90M 4842.10M 5151.70M
Other current liab 455.30M 495.20M 625.90M 576.30M 1176.70M
Common stock 6608.20M 6733.90M 6837.50M 6936.70M 7043.20M
Retained earnings -3677.50M -2252.10M -2080.30M -2067.60M -1927.00M
Other liab - - - 801.70M 622.10M
Good will 2050.10M 3320.20M 3529.10M 3490.40M 2999.40M
Other assets - - - 240.20M 287.90M
Cash 531.60M 558.80M 751.30M 600.70M 1864.90M
Total current liabilities 1012.90M 1044.20M 1586.30M 1113.60M 1587.90M
Current deferred revenue - - -440.60M - -
Net debt 3437.30M 3059.30M 3322.10M -600.70M -1864.90M
Short term debt 62.30M 36.40M 440.60M - -
Short long term debt total 3968.90M 3618.10M 4073.40M - -
Other stockholder equity -9.30M -136.50M -135.50M -27.00M 35.50M
Property plant equipment - - - 1165.40M 1058.90M
Total current assets 2797.40M 2481.90M 2832.90M 2719.90M 3859.90M
Net tangible assets - - - -1937.10M 0.90M
Short term investments - - 0.10M 0.10M 0.40M
Net receivables 612.80M 642.30M 739.60M 738.60M 693.10M
Inventory 1149.00M 1081.80M 1140.90M 1150.30M 1020.20M
Accounts payable 474.50M 495.20M 477.70M 537.30M 411.20M
Accumulated other comprehensive income 14.10M -162.40M 10.70M - -
Non currrent assets other 236.40M 318.60M 335.20M -8057.20M -6277.90M
Non current assets total 5737.80M 7165.80M 7976.20M 8057.20M 6277.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - 100.30M -7.90M
Total cashflows from investing activities -75.40M 78.80M -77.50M -1958.60M 1275.80M
Net borrowings - - - 616.70M -30.60M
Total cash from financing activities -220.50M -611.00M -187.20M 421.60M -178.70M
Change to operating activities - - - 44.20M -77.70M
Net income -1402.30M -171.80M -12.70M -140.60M -68.90M
Change in cash -27.20M -192.50M 150.60M -1278.60M 1237.80M
Begin period cash flow 558.80M 751.30M 600.70M 1879.30M 641.50M
End period cash flow 531.60M 558.80M 751.30M 600.70M 1879.30M
Total cash from operating activities 238.50M 362.90M 405.50M 307.30M 156.30M
Depreciation 337.50M 325.90M 359.50M 338.60M 312.20M
Other cashflows from investing activities 18.00M 197.10M 24.20M 61.70M 2.80M
Dividends paid 159.30M 152.50M 149.70M 142.40M 129.60M
Change to inventory -61.10M 13.70M 19.40M -76.70M -2.40M
Change to account receivables 30.70M -11.10M -57.10M 0.10M -159.70M
Other cashflows from financing activities -26.40M -20.70M -7.30M 1534.60M -18.50M
Change to netincome - - - 89.30M 208.40M
Capital expenditures 93.40M 118.30M 101.70M 96.40M 222.70M
Change in working capital -101.10M -74.70M -58.50M -76.60M -162.10M
Stock based compensation 54.60M 64.40M 68.80M 54.90M 57.00M
Other non cash items 1455.20M 209.30M 155.00M 131.00M 18.10M
Free cash flow 145.10M 244.60M 303.80M 210.90M -66.40M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0Y5E
Perrigo Co. PLC		 -0.01
0.06%		 15.79 - - 0.35 -
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Perrigo Co. PLC

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

The Sharp Building, Dublin, Ireland, D02 TY74

353 1 709 4000

https://www.perrigo.com

8100

Name Title Year Born
Mr. Murray S. Kessler CEO, Pres & Director 1960
Mr. Svend Andersen Exec. VP & Pres of Consumer Self-Care International 1962
Mr. James E. Dillard III Exec. VP & Pres of Consumer Self-Care Americas 1964
Mr. Eduardo Guarita Bezerra Exec. VP & CFO 1975
Mr. Ronald C. Janish Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain 1966
Mr. Shannon Hukill Sr. Director of Technical Operations NA
Mr. Thomas M. Farrington Chief Information Officer & Exec. VP 1957
Ms. Alison Ives Exec. VP & Chief Scientific Officer NA
Mr. Bradley Joseph VP of Global Investor Relations & Corp. Communications NA
Ms. Kyle L. Hanson Exec. VP, Gen. Counsel & Corp. Sec. 1965

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…